Effectiveness of the Pikluc® to relieve pain of intramuscular injection in children and adolescents

Not Applicable

• Conditions: Acute Pain; C23.888.592.612

• Registration Number: RBR-10kxn5rs
• Lead Sponsor: niversidade Federal de Santa Catarina

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-07-03
• Last Update Posted: 26 July 2023
• Study Completion: 2023-12-01

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Medical indication for intramuscular injection, in the right or left ventro-gluteal region or right or left deltoid region; to have the possibility of body weighing and height measurement; to be aged between 4 and 15 years; both genders

Exclusion Criteria

Cognitive deficit; psychiatric disorders; diseases that felt sensitivity to pain; having ingested substances that affect sensitivity to pain; people who underwent invasive procedures on the same day as the intramuscular injection

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Expected outcome 1: Pain relief reported by the child/adolescent and verified through the researcher's perception according to the Faces Pain Scale-Revised is expected when intramuscular injections are performed using the Pikluc® device

Secondary Outcome Measures

Name	Time	Method
Expected outcome 2: An improvement in the behavior of the child/adolescent is expected through the four categories of the Observation Scale of Behavior Distress when Pikluc® is used during intramuscular injections.